Delap Wealth Advisory’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,234
Closed -$39.9K 99
2024
Q2
$39.9K Buy
+14,234
New +$38.2K 0.02% 115

Other funds holding ORGO

Delap Wealth Advisory's ORGO Position: Q3 2024 in Review

Delap Wealth Advisory sold out of Organogenesis Holdings (ORGO) in Q3 2024, closing a stake of 14,234 shares — an estimated $39.9K sold.

Delap Wealth Advisory first reported a position in ORGO in Q2 2024 and held it in 1 quarter. The position peaked at $39.9K in Q2 2024. 112 funds tracked by Wall St. Rank hold ORGO as of Q3 2024.

  • Delap Wealth Advisory reported no remaining Organogenesis Holdings position as of Q3 2024 after selling out during the quarter.
  • Delap Wealth Advisory sold 14,234 Organogenesis Holdings shares in Q3 2024, an estimated $39.9K.
  • Delap Wealth Advisory first reported a position in Organogenesis Holdings in Q2 2024 and held it in 1 quarter.
  • Delap Wealth Advisory's Organogenesis Holdings position peaked at $39.9K in Q2 2024.
  • 112 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2024.

Based on Delap Wealth Advisory's 13F filing for Q3 2024, filed 12 Nov 2024.